Type 2 versus type 1 myocardial infarction: A comparison of clinical characteristics and outcomes with a meta-analysis of observational studies

Cardiovascular Diagnosis and Therapy

Volumn 7, Issue 4, 2017, Pages 348-358

  Gupta, Sonu ^a   Vaidya, Satyanarayana R ^a   Arora, Sameer ^a,b   Bahekar, Amol ^a   Devarapally, Santhosh R ^a,c  

^a Cape Fear Valley Medical Center   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Type 1 MI; Type 2 MI; Universal definition of MI

Indexed keywords

EID: 85028329264     PISSN: 22233652     EISSN: 22233660     Source Type: Journal    
DOI: 10.21037/cdt.2017.03.21     Document Type: Article

References (35)

1. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
2. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Glob Heart 2012;7:275-95.
3. Alpert JS, Thygesen KA, White HD, et al. Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. Am J Med 2014;127:105-8.
4. Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 2010;139:228-33.
5. Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9-13.
6. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789-97.
7. Gonzalez MA, Eilen DJ, Marzouq RA, et al. The universal classification is an independent predictor of long-term outcomes in acute myocardial infarction. Cardiovasc Revasc Med 2011;12:35-40.
8. Saaby L, Poulsen TS, Diederichsen AC, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 2014;127:295-302.
9. Sandoval Y, Smith SW, Apple FS. Type 2 myocardial infarction: the next frontier. Am J Med 2014;127:e19.
10. Bonaca M P, Wiviott SD, Braunwald E, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation 2012;125:577-83.
11. López-Cuenca A, Gomez-Molina M, Flores-Blanco PJ, et al. Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes. J Geriatr Cardiol 2016;13:15-22.
12. Baron T, Hambraeus K, Sundstrom J, et al. Type 2 myocardial infarction in clinical practice. Heart 2015;101:101-6.
13. Stein GY, Herscovici G, Korenfeld R, et al. Type-II myocardial infarction-patient characteristics, management and outcomes. PLoS One 2014;9:e84285.
14. Landes U, Bental T, Orvin K, et al. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction. J Cardiol 2016;67:51-6.
15. El-haddad H RE, Swett K. prognostic implications of type 2 myocardial infarctions. world J cardiovasc Dis 2012:237-41.
16. Shah AS, McAllister DA, Mills R, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med 2015;128:493-501.e3.
17. Higgins J GS. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. 2008.
18. Moher D CD, Eastwood S. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900.
19. Moher D LA, Tetzlaff J. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12.
20. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5.
21. Higgins J P, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj 2003;327:557-60.
22. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
23. Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 2011;124:381-7.
24. Kim M, Son M, Lee DH, et al. Troponin-I Level After Major Noncardiac Surgery and Its Association With Long-Term Mortality. Int Heart J 2016;57:278-84.
25. Gualandro DM, Campos CA, Calderaro D, et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 2012;222:191-5.
26. Sametz W, Metzler H, Gries M, et al. Perioperative catecholamine changes in cardiac risk patients. Eur J Clin Invest 1999;29:582-7.
27. Ammann P, Fehr T, Minder EI, et al. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001;27:965-9.
28. Kumar A, Thota V, Dee L, et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996;183:949-58.
29. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med 2011;154:523-8.
30. de Araújo Gonçalves P, Ferreira J, Aguiar C, et al. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005;26:865-72.
31. Banihashemi B, Goodman SG, Yan RT, et al. Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience. Am Heart J 2009;158:917-24.
32. Fox KA, Anderson FA, Jr., Dabbous OH, et al. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007;93:177-82.
33. Díaz-Garzón J, Sandoval Y, Smith SW, et al. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction. Clin Chem 2017;63:415-9.
34. Mendis S, Thygesen K, Kuulasmaa K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011;40:139-46.
35. Coordination and Maintenance Committee Meeting. CDC. ICD-10; 2016 March 9-10.